Home Industry Reports Custom Research Blogs About Us Contact us

Point-of-Care Glucose Testing Market Size & Share, By Product (Lancing Devices and Strips, Blood-Glucose Meter), Application (Type-1 Diabetes, Type-2 Diabetes), End User (Hospitals and Clinics, Home Care Settings, Others), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Report ID: FBI 5448

|

Published Date: Aug-2024

|

Format : PDF, Excel

Market Outlook:

Point-of-Care Glucose Testing Market was over USD 3.54 Billion in 2023 and is predicted to surpass USD 5.08 Billion by end of the year 2032, witnessing more than 4.1% CAGR between 2024 and 2032.

Base Year Value (2023)

USD 3.54 Billion

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

4.1%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 5.08 Billion

19-23 x.x %
24-32 x.x %
Point-of-Care Glucose Testing Market

Historical Data Period

2019-2023

Point-of-Care Glucose Testing Market

Largest Region

North America

Point-of-Care Glucose Testing Market

Forecast Period

2024-2032

Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunity:

Point-of-Care Glucose Testing Market is expected to witness significant growth in the coming years due to the increasing prevalence of diabetes worldwide. The rising incidence of diabetes, coupled with the growing awareness about the importance of regular glucose monitoring, is driving the demand for point-of-care glucose testing devices. Additionally, the convenience and accuracy offered by these devices are further fueling market growth.

Report Scope

Report CoverageDetails
Segments CoveredProduct, Application, End User
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledAbbott, Dexcom, Roche, Ascensia Diabetes Care, LifeScan, Medtronic, Ypsomed, Animas, Insulet, Bayer, Nipro, Terumo, Arkray, Acon Laboratories

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

However, despite the promising growth prospects, the Point-of-Care Glucose Testing Market is facing challenges in terms of stringent regulatory requirements. The approval process for glucose testing devices can be time-consuming and costly, which may hinder market growth. Furthermore, the lack of reimbursement policies for point-of-care testing devices is also acting as a restraint for the market. Without adequate reimbursement, patients may be reluctant to invest in these devices, impacting the overall market growth.

Regional Forecast:

Point-of-Care Glucose Testing Market

Largest Region

North America

41% Market Share in 2023

Get more details on this report -

North America:

In North America, the Point-of-Care Glucose Testing Market is driven by high prevalence of diabetes, increasing adoption of advanced healthcare technologies, and favorable reimbursement policies. The United States dominates the market in this region, followed by Canada. Continuous advancements in glucose monitoring devices and rising awareness about the importance of regular glucose screening are contributing to the growth of the market in North America.

2. Asia Pacific:

In Asia Pacific, the Point-of-Care Glucose Testing Market is witnessing significant growth due to the increasing diabetic population, rising healthcare expenditure, and growing awareness about the benefits of early diabetes detection. China, Japan, and South Korea are the major contributors to the market in this region. The adoption of point-of-care glucose testing devices is increasing in Asia Pacific, supported by government initiatives to improve healthcare infrastructure.

3. Europe:

In Europe, the Point-of-Care Glucose Testing Market is driven by the high prevalence of diabetes, increasing geriatric population, and favorable regulatory environment. The United Kingdom, Germany, and France are the key markets for point-of-care glucose testing in Europe. Technological advancements in glucose monitoring devices, along with the presence of key players in the region, are propelling the market growth in Europe.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Point-of-Care Glucose Testing Market
Point-of-Care Glucose Testing Market

Segmentation Analysis:

""

In terms of segmentation, the global Point-of-Care Glucose Testing market is analyzed on the basis of Product, Application, End User.

Product Analysis:

Lancing Devices and Strips segment: The lancing devices and strips segment in the Point-of-Care Glucose Testing Market are essential components for obtaining blood samples for glucose testing. These products are widely used in various healthcare settings, including hospitals, clinics, and home care settings. The demand for lancing devices and strips is expected to witness significant growth due to the increasing prevalence of diabetes worldwide.

Blood-Glucose Meter segment: The blood-glucose meter segment in the Point-of-Care Glucose Testing Market includes handheld devices that are used to measure blood glucose levels. These meters are crucial for individuals with diabetes to monitor their blood sugar levels regularly. The market for blood-glucose meters is anticipated to grow with technological advancements and the rising awareness about the importance of self-monitoring blood glucose levels.

Application Analysis:

Type-1 Diabetes segment: The Point-of-Care Glucose Testing Market caters to individuals with Type-1 Diabetes, who require regular monitoring of their blood glucose levels. The market for point-of-care glucose testing in Type-1 Diabetes is driven by the increasing incidence of the disease and the growing need for effective management and control of blood glucose levels.

Type-2 Diabetes segment: The Point-of-Care Glucose Testing Market also serves individuals with Type-2 Diabetes, which accounts for the majority of diabetes cases globally. The market for point-of-care glucose testing in Type-2 Diabetes is expected to witness significant growth due to the rising prevalence of the disease and the increasing adoption of self-monitoring techniques for managing diabetes.

End User Analysis:

Hospitals and Clinics segment: Hospitals and clinics are key end users of point-of-care glucose testing products, as they provide diagnostic and treatment services to individuals with diabetes. The demand for glucose testing products in hospitals and clinics is driven by the growing burden of diabetes and the need for accurate and timely monitoring of blood glucose levels in healthcare settings.

Home Care Settings segment: The Point-of-Care Glucose Testing Market caters to individuals with diabetes who prefer to monitor their blood glucose levels at home. Home care settings offer convenience and ease of access for patients with diabetes, leading to the increasing adoption of point-of-care glucose testing products in this segment. The market for point-of-care glucose testing in home care settings is projected to grow with the rising trend of self-management of diabetes.

Get more details on this report -

Competitive Landscape:

The competitive landscape in the Point-of-Care Glucose Testing Market is characterized by a diverse range of players offering innovative products to meet the growing demand for rapid and accurate glucose monitoring. Key firms are focusing on advancements in technology, such as integration with mobile health applications and enhanced connectivity features, to enhance user experience and improve clinical outcomes. Strategic partnerships and alliances are common among companies seeking to expand their market presence and leverage each other's strengths. Additionally, regulatory approvals and compliance with stringent quality standards are vital for market competitiveness, prompting companies to invest in research and development. As the prevalence of diabetes continues to rise globally, the competition is expected to intensify, driving further innovation and market expansion.

Top Market Players

- Abbott Laboratories

- Roche Diagnostics

- Johnson & Johnson

- Medtronic

- Ascensia Diabetes Care

- Dexcom

- Ascensia Diabetes Care

- Arkray, Inc.

- Siemens Healthineers

- Trividia Health

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Point-of-Care Glucose Testing Market Size & Share,...

RD Code : 24